Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04896476 · ClinicalTrials.gov registry record · NA
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
A NA study of Kidney Diseases and Arteriovenous Fistula, sponsored by Sonavex.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 4
- Study locations
NCT04896476: Active NA study of Kidney Diseases and Arteriovenous Fistula, sponsored by Sonavex.
NCT04896476 is a NA study of Kidney Diseases and Arteriovenous Fistula that is active but no longer recruiting, run by Sonavex. The registered enrollment target is 20 participants, below the 1,785-participant average among 38 other Kidney Diseases trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04896476, a NA study of Kidney Diseases and Arteriovenous Fistula, is active but no longer recruiting, sponsored by Sonavex.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 4
- Study locations
Study Summary
Multi-center trial to assess the feasibility and safety of the EchoMark LP and the EchoMark diagnostic ultrasound system for assessing AV fistula blood flow, diameter, and depth.
Primary Outcome
Composite of new major device related adverse events (MAEs) at 30 days post EchoMark implantation, as adjudicated by the Clinical Events Committee (CEC) including: * Device or procedure-related death * Device related infection * Device related interventions * Device related hospitalizations * Fistula failure * Fistula rupture * Aneurysm
Conditions Studied
Interventions
- DEVICE EchoMark / EchoSure
Study Locations (4)
Alabama
- Trinity Research Group - Dothan
Arizona
- SKI Vascular Center - Peoria
Michigan
- Michgan Vascular Center - Flint
North Carolina
- Surgical Specialist of Charlotte - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-01-21 |
| Est. Completion | 2025-06-06 |
| Phase | NA |
What the registry record for NCT04896476 still lists
NCT04896476 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,785-participant average among 38 other Kidney Diseases trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which EchoMark / EchoSure is the first listed.
NCT04896476 reports a single indexed study location in Alabama, Arizona, Michigan.
Frequently Asked Questions
What is clinical trial NCT04896476 about?
NCT04896476 is a clinical study titled "Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae". Multi-center trial to assess the feasibility and safety of the EchoMark LP and the EchoMark diagnostic ultrasound system for assessing AV fistula blood flow, diameter, and depth.
What is the current status of trial NCT04896476?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-01-21. Estimated completion is 2025-06-06.
What conditions does trial NCT04896476 study?
This clinical trial studies the following conditions: Kidney Diseases, Arteriovenous Fistula.
What interventions are being tested in trial NCT04896476?
The interventions under investigation include: EchoMark / EchoSure (DEVICE).
Who is sponsoring clinical trial NCT04896476?
This trial is sponsored by Sonavex, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04896476 being conducted?
This trial has 4 study locations across Alabama, Arizona, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04896476's enrollment target sits among peer trials
20 36th of 38 higher than 2 of 38 other Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
RECRUITING · NA
-
Supporting VETerans With Kidney Disease Through Food As Medicine
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
-
Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI